沙欣重新提出两党法案, 将胰岛素的成本限制在大多数美国人的35美元. Shaheen reintroduces bipartisan bill capping insulin costs at $35 for most Americans.

两党参议员团由珍妮·沙欣领导重新提出了2026年胰岛素法案, 将大多数美国人的月度胰岛症费用限制在35美元, 并扩大目前医疗保险受益者的福利. A bipartisan group of senators led by Jeanne Shaheen has reintroduced the INSULIN Act of 2026 to cap monthly insulin costs at $35 for most Americans, extending a benefit currently available to Medicare recipients. 该法案将取消保险覆盖的胰岛素自扣费用,并从2027年开始限制自付成本,旨在解决2026年中期选举之前的负担能力问题. The bill would eliminate deductibles for covered insulin and limit out-of-pocket costs starting in 2027, aiming to address affordability concerns ahead of the 2026 midterms.